These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-Transfusion-Dependent Thalassemia: A Panoramic Review. Shash H Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295656 [TBL] [Abstract][Full Text] [Related]
3. Non-transfusion Dependent Thalassemias: A Developing Country Perspective. Mukherjee S; Das RR; Raghuwanshi B Curr Pediatr Rev; 2015; 11(2):87-97. PubMed ID: 26133180 [TBL] [Abstract][Full Text] [Related]
4. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Vichinsky E Curr Med Res Opin; 2016; 32(1):191-204. PubMed ID: 26479125 [TBL] [Abstract][Full Text] [Related]
5. Clinical Classification, Screening and Diagnosis for Thalassemia. Viprakasit V; Ekwattanakit S Hematol Oncol Clin North Am; 2018 Apr; 32(2):193-211. PubMed ID: 29458726 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in the molecular understanding of non-transfusion-dependent thalassemia. Galanello R Blood Rev; 2012 Apr; 26 Suppl 1():S7-S11. PubMed ID: 22631043 [TBL] [Abstract][Full Text] [Related]
7. Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management. Sleiman J; Tarhini A; Bou-Fakhredin R; Saliba AN; Cappellini MD; Taher AT Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316681 [TBL] [Abstract][Full Text] [Related]
8. Morbidities in non-transfusion-dependent thalassemia. Saliba AN; Taher AT Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941 [TBL] [Abstract][Full Text] [Related]
9. Clinical Complications and Their Management. Marcon A; Motta I; Taher AT; Cappellini MD Hematol Oncol Clin North Am; 2018 Apr; 32(2):223-236. PubMed ID: 29458728 [TBL] [Abstract][Full Text] [Related]
11. New strategies in the treatment of the thalassemias. Schrier SL; Angelucci E Annu Rev Med; 2005; 56():157-71. PubMed ID: 15660507 [TBL] [Abstract][Full Text] [Related]
15. Increasing prevalence of thalassemia in America: Implications for primary care. Sayani FA; Kwiatkowski JL Ann Med; 2015; 47(7):592-604. PubMed ID: 26541064 [TBL] [Abstract][Full Text] [Related]
16. Unmet needs in β-thalassemia and the evolving treatment landscape. Njeim R; Naouss B; Bou-Fakhredin R; Haddad A; Taher A Transfus Clin Biol; 2024 Feb; 31(1):48-55. PubMed ID: 38128605 [TBL] [Abstract][Full Text] [Related]
17. Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias. Ozturk Z; Gumuslu S; Yalcin K; Kupesiz A J Pediatr Hematol Oncol; 2021 Jul; 43(5):186-192. PubMed ID: 34157011 [TBL] [Abstract][Full Text] [Related]
18. Thalassemia: current approach to an old disease. Lo L; Singer ST Pediatr Clin North Am; 2002 Dec; 49(6):1165-91, v. PubMed ID: 12580361 [TBL] [Abstract][Full Text] [Related]
19. Iron overload in thalassemia: different organs at different rates. Taher AT; Saliba AN Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):265-271. PubMed ID: 29222265 [TBL] [Abstract][Full Text] [Related]